Science Explorer Back to mapMap

Most cited papers from MDxHealth (Netherlands)

What are the most cited papers from MDxHealth (Netherlands)?

The most cited paper from MDxHealth (Netherlands) is "Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score" (Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra et al., 2016), with 380 citations. Next come "Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men" (86) and "Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen" (68).

Showing 29 of 29 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score Leander Van Neste, Rianne J. Hendriks, Siebren Dijkstra et al. · European Urology Open access 30 Apr 2016 380
2 Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men Rianne J. Hendriks, Marloes M. G. van der Leest, Bas Israël et al. · Prostate Cancer and Prostatic Diseases Open access 3 May 2021 86
3 Biomarkers for detection and prognosis of breast cancer identified by a functional hypermethylome screen Jana Jeschke, Leander Van Neste, Sabine C. Glöckner et al. · Epigenetics Open access Jul 2012 68
4 Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study Tim Martin Govers, Daphne Hessels, Virginie Vlaeminck‐Guillem et al. · Prostate Cancer and Prostatic Diseases 20 Aug 2018 67
5 miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2 Jasmijn G.M. van Kampen, Onno van Hooij, Cornelius F. Jansen et al. · Cancer Research 16 Feb 2017 58
6 DNA Methylation of Phosphatase and Actin Regulator 3 Detects Colorectal Cancer in Stool and Complements FIT Linda J.W. Bosch, Frank A. Oort, Maarten Neerincx et al. · Cancer Prevention Research 3 Dec 2011 55
7 Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study Guillemette Emma Benoist, Inge M. van Oort, Emmy Boerrigter et al. · Clinical Chemistry Open access 2 Apr 2020 41
8 Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population Priscilla Brebi, Leonel Maldonado, Maartje G. Noordhuis et al. · Epigenetics Open access 15 Nov 2013 36
9 Suppression of prostate tumor cell survival by antisense oligonucleotide-mediated inhibition of AR-V7 mRNA synthesis Maria V. Luna Velez, Gerald W.C.T Verhaegh, Frank P. Smit et al. · Oncogene Open access 21 Jan 2019 34
10 Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis Wieke C. H. Visser, Hans de Jong, Willem J. G. Melchers et al. · Cancers Open access 16 Dec 2020 30
11 Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer Cindy Rönnau, Sebastian Fussek, Frank P. Smit et al. · World Journal of Urology Open access 14 May 2021 29
12 Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research Anobel Y. Odisho, Mark Bridge, Mitchell Webb et al. · JCO Clinical Cancer Informatics Open access 17 Jul 2019 29
13 Clinical use of the mRNA urinary biomarker SelectMDx test for prostate cancer Wieke C. H. Visser, Hans de Jong, Sandra Steyaert et al. · Prostate Cancer and Prostatic Diseases Open access 9 Jul 2022 24
14 Mental health symptoms as prognostic risk markers of all-cause and psychiatric sickness absence in office workers C. A. M. Roelen, Rob Hoedeman, Willem van Rhenen et al. · European Journal of Public Health Open access 13 Mar 2013 20
15 Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration‐resistant prostate cancer undergoing first‐line abiraterone acetate and prednisone treatment Emmy Boerrigter, Guillemette Emma Benoist, Inge M. van Oort et al. · Molecular Oncology Open access 2 Mar 2021 19
16 Recent developments in computer assisted rehabilitation environments Rob van der Meer · Military Medical Research Open access 2014 17
17 The recovery experience of people who were sex trafficked: the thwarted journey towards goal pursuit Roderik F. Viergever, Nicki Thorogood, Tamara van Driel et al. · BMC International Health and Human Rights Open access 22 Jan 2019 13
18 Androgen receptor signalling confers clonogenic and migratory advantages in urothelial cell carcinoma of the bladder Maria V. Luna Velez, Jelmer J. Dijkstra, Marina Augusto Heuschkel et al. · Molecular Oncology Open access 2 Apr 2021 12
19 Analytical validation of an mRNA-based urine test to predict the presence of high-grade prostate cancer Daphne Hessels, Hans de Jong, Sander A. Jannink et al. · Translational Medicine Communications Open access 11 May 2017 10
20 Defining operations and maintenance in web engineering: A framework for CMS-based Web applications Jurriaan Souer, Paul Honders, Johan Versendaal et al. Conference paper 2007 10
21 Sustained Postnatal Skin Regeneration Upon Prenatal Application of Functionalized Collagen Scaffolds Corien Oostendorp, Paul J. Geutjes, Frank P. Smit et al. · Tissue Engineering Part A 15 Nov 2019 9
22 RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Emmy Boerrigter, Guillemette Emma Benoist, Inge M. van Oort et al. · Cancers Open access 14 Dec 2021 7
23 The Androgen Regulated lncRNA NAALADL2-AS2 Promotes Tumor Cell Survival in Prostate Cancer Levi Groen, Viktor Yurevych, Harshitha Ramu et al. · Non-Coding RNA Open access Dec 2022 5
24 Initial Findings from a High Genetic Risk Prostate Cancer Clinic Michael S. Sessine, Sanjay Kumar Das, Bumsoo Park et al. · Urology 16 Jul 2021 5
25 Discovery of RNA Biomarkers for Prostate Cancer Using Cross-Platform Transcriptomics Wieke C. H. Visser, Hans de Jong, Frank P. Smit et al. · International Journal of Molecular Sciences Open access 6 Nov 2024 2
26 Clinically significant Prostate Cancer diagnosed using a urinary molecular biomarker-based risk score: two case reports Pieter Minnee, Daphne Hessels, Jack A. Schalken et al. · BMC Urology Open access 29 Nov 2019 2
27 The Role of MCDA in Health Research Priority Setting Roderik F. Viergever, Dimitrios Gouglas, Noor B. Tromp Book chapter 2017 1
28 Embedding MCDA in Priority-Setting Policy Processes: Experiences from Low- and Middle-Income Countries Noor B. Tromp, Evelinn Mikkelsen, Roderik F. Viergever et al. Book chapter 2017 1
29 Impact of Heterogeneous DNA Methylation on the Accuracy of Quantitative Methylation-Specific PCR for Detecting DNA Hypermethylation in Prostate Cancer Wieke C. H. Visser, Hans de Jong, Laureen B. Janssen et al. · International Journal of Molecular Sciences Open access 27 Feb 2026 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.